Related Experiment Video
Updated: Jun 27, 2025
07:03
Isolation and Functional Assessment of Human Breast Cancer Stem Cells from Cell and Tissue Samples
Published on: October 2, 2020
4.5K
Ginseng-derived compounds as potential anticancer agents targeting cancer stem cells
Ji-Sun Lee1, Ho-Young Lee2,3
1Department of Molecular, Cell & Cancer Biology, University of Massachusetts Chan Medical School, Worcester, MA, USA.
Journal of Ginseng Research
|May 6, 2024
Summary
Cancer stem cells (CSCs) drive tumor growth and recurrence. Ginseng compounds show promise in targeting these cells, offering a potential new strategy against cancer therapy limitations.
Area of Science:
- Oncology
- Pharmacology
- Natural Products
Background:
- Cancer stem cells (CSCs) are crucial for tumor initiation, progression, and recurrence.
- Current cancer therapies struggle to eradicate CSCs, leading to treatment limitations.
- Ginseng possesses known pharmacological properties, including anticancer effects.
Purpose of the Study:
- To review the biology of cancer stem cells.
- To explore the potential of ginseng-derived compounds as anti-CSC agents.
- To highlight how ginseng components can overcome current therapeutic challenges.
Main Methods:
- Literature review of CSC biology.
- Analysis of studies on ginseng's bioactive compounds and their anti-CSC activities.
- Synthesis of findings on ginseng's role in targeting CSCs.
Main Results:
- Ginseng contains bioactive compounds like ginsenosides and non-saponins.
- These compounds exhibit anticancer properties and have shown potential against CSCs.
- Ginseng-derived agents may offer a novel approach to overcome CSC-related therapeutic resistance.
Conclusions:
- Ginseng-derived compounds represent a promising avenue for developing novel anti-CSC therapies.
- Targeting CSCs with natural products like ginseng could improve cancer treatment outcomes.
- Further research is warranted to optimize ginseng-based strategies for cancer eradication.
More Related Videos
Related Concept Videos
02:40Cancer Stem Cells and Tumor Maintenance
4.9K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.9K
02:57Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
02:38Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K